Profund Advisors LLC boosted its holdings in Cigna Corporation (NYSE:CI) by 2.8% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,646 shares of the health services provider’s stock after purchasing an additional 287 shares during the quarter. Profund Advisors LLC’s holdings in Cigna Corporation were worth $1,782,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. American Beacon Advisors Inc. acquired a new stake in shares of Cigna Corporation in the first quarter valued at approximately $102,000. Founders Capital Management acquired a new stake in shares of Cigna Corporation in the first quarter valued at approximately $117,000. Parallel Advisors LLC boosted its holdings in shares of Cigna Corporation by 62.3% in the second quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock valued at $139,000 after acquiring an additional 307 shares during the period. Mckinley Capital Management LLC Delaware acquired a new stake in shares of Cigna Corporation in the first quarter valued at approximately $122,000. Finally, Guardian Life Insurance Co. of America boosted its holdings in shares of Cigna Corporation by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 990 shares of the health services provider’s stock valued at $145,000 after acquiring an additional 7 shares during the period. 87.94% of the stock is owned by hedge funds and other institutional investors.
Several equities research analysts have recently weighed in on CI shares. ValuEngine downgraded Cigna Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 20th. Credit Suisse Group started coverage on Cigna Corporation in a report on Monday, June 12th. They issued an “outperform” rating and a $185.00 price objective for the company. CIBC increased their price objective on Cigna Corporation from $174.00 to $185.00 and gave the company an “outperform” rating in a report on Thursday, June 15th. Royal Bank Of Canada reissued a “buy” rating and issued a $177.00 price objective on shares of Cigna Corporation in a report on Tuesday, June 13th. Finally, Bank of America Corporation increased their price objective on Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a report on Friday, June 23rd. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. Cigna Corporation has an average rating of “Buy” and an average target price of $182.59.
In other news, Director William D. Zollars sold 1,232 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total value of $230,667.36. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Matthew G. Manders sold 24,357 shares of the business’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $175.01, for a total value of $4,262,718.57. Following the completion of the sale, the insider now directly owns 46,256 shares in the company, valued at approximately $8,095,262.56. The disclosure for this sale can be found here. Insiders have sold a total of 70,653 shares of company stock valued at $12,437,684 in the last quarter. 1.30% of the stock is currently owned by insiders.
Cigna Corporation (NYSE:CI) traded down 0.23% on Monday, reaching $185.63. The company’s stock had a trading volume of 27,978 shares. The firm has a 50-day moving average price of $179.52 and a 200 day moving average price of $165.10. Cigna Corporation has a 52-week low of $115.03 and a 52-week high of $188.36. The firm has a market capitalization of $46.74 billion, a P/E ratio of 21.42 and a beta of 0.43.
Cigna Corporation (NYSE:CI) last announced its quarterly earnings results on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The company had revenue of $10.32 billion during the quarter, compared to analyst estimates of $10.26 billion. During the same quarter in the previous year, the firm posted $1.98 EPS. The firm’s quarterly revenue was up 3.6% on a year-over-year basis. Equities analysts anticipate that Cigna Corporation will post $10.02 earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: “Cigna Corporation (CI) Shares Bought by Profund Advisors LLC” was originally posted by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece on another publication, it was illegally copied and republished in violation of US and international copyright & trademark law. The original version of this piece can be accessed at https://transcriptdaily.com/2017/09/18/cigna-corporation-ci-shares-bought-by-profund-advisors-llc.html.
Cigna Corporation Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.